Cargando…
Commentary: HNRNPLL, a newly identified colorectal cancer metastasis suppressor, modulates alternative splicing of CD44 during epithelial-mesenchymal transition
Autor principal: | Baranwal, Somesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5650611/ https://www.ncbi.nlm.nih.gov/pubmed/29085822 http://dx.doi.org/10.3389/fcell.2017.00091 |
Ejemplares similares
-
Differential Requirement for the CD45 Splicing Regulator hnRNPLL for Accumulation of NKT and Conventional T Cells
por: Yabas, Mehmet, et al.
Publicado: (2011) -
The RNA-binding protein hnRNPLL induces a T cell alternative splicing program delineated by differential intron retention in polyadenylated RNA
por: Cho, Vicky, et al.
Publicado: (2014) -
Cortactin in Epithelial–Mesenchymal Transition
por: Ji, Rong, et al.
Publicado: (2020) -
The Construction of Bone Metastasis-Specific Prognostic Model and Co-expressed Network of Alternative Splicing in Breast Cancer
por: Huang, Runzhi, et al.
Publicado: (2020) -
Targeting alternative splicing in cancer immunotherapy
por: Han, Nan, et al.
Publicado: (2023)